2024 Q1 Form 10-Q Financial Statement

#000117351424000072 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $1.057B $1.027B
YoY Change 5.72% 4.26%
Cost Of Revenue $820.8M $817.5M
YoY Change -0.5% -2.5%
Gross Profit $235.7M $209.7M
YoY Change 35.15% 42.94%
Gross Profit Margin 22.31% 20.41%
Selling, General & Admin $151.9M $161.0M
YoY Change 15.25% 26.87%
% of Gross Profit 64.45% 76.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.70M $11.30M
YoY Change 4.46% 8.65%
% of Gross Profit 4.96% 5.39%
Operating Expenses $151.9M $161.0M
YoY Change 15.25% 26.87%
Operating Profit $83.80M $48.70M
YoY Change 96.71% 145.96%
Interest Expense $8.900M -$7.100M
YoY Change -12.75% -13.41%
% of Operating Profit 10.62% -14.58%
Other Income/Expense, Net -$6.900M $100.0K
YoY Change 2.99% -93.33%
Pretax Income $76.90M $41.70M
YoY Change 114.21% 218.32%
Income Tax $25.10M $16.00M
% Of Pretax Income 32.64% 38.37%
Net Earnings $51.50M $25.20M
YoY Change 93.61% 231.58%
Net Earnings / Revenue 4.87% 2.45%
Basic Earnings Per Share $2.97
Diluted Earnings Per Share $2.93 $1.43
COMMON SHARES
Basic Shares Outstanding 17.34M shares
Diluted Shares Outstanding 17.59M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $62.20M $78.80M
YoY Change -3.72% 33.56%
Cash & Equivalents $62.20M $78.80M
Short-Term Investments
Other Short-Term Assets $101.4M $98.10M
YoY Change 14.71% 28.07%
Inventory $841.9M $815.7M
Prepaid Expenses
Receivables $520.5M $497.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.526B $1.490B
YoY Change -1.14% 2.15%
LONG-TERM ASSETS
Property, Plant & Equipment $311.9M $313.9M
YoY Change 2.53% 1.26%
Goodwill $52.00M $53.30M
YoY Change -0.57% 3.9%
Intangibles $37.30M $39.30M
YoY Change -12.65% -7.96%
Long-Term Investments $52.10M $56.80M
YoY Change -6.46% -4.38%
Other Assets $136.1M $122.7M
YoY Change 38.59% 20.89%
Total Long-Term Assets $592.4M $589.0M
YoY Change 6.6% 3.79%
TOTAL ASSETS
Total Short-Term Assets $1.526B $1.490B
Total Long-Term Assets $592.4M $589.0M
Total Assets $2.118B $2.079B
YoY Change 0.91% 2.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $565.9M $523.5M
YoY Change -6.89% -10.64%
Accrued Expenses $51.60M $87.40M
YoY Change 19.17% 35.71%
Deferred Revenue
YoY Change
Short-Term Debt $69.80M $83.30M
YoY Change -49.96% -39.24%
Long-Term Debt Due $165.3M $169.4M
YoY Change 3.51% 13.84%
Total Short-Term Liabilities $1.221B $1.219B
YoY Change -11.88% -9.26%
LONG-TERM LIABILITIES
Long-Term Debt $239.7M $241.3M
YoY Change -8.3% -9.63%
Other Long-Term Liabilities $165.8M $143.4M
YoY Change 30.35% 3.84%
Total Long-Term Liabilities $165.8M $143.4M
YoY Change 30.35% 3.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.221B $1.219B
Total Long-Term Liabilities $165.8M $143.4M
Total Liabilities $1.689B $1.672B
YoY Change -7.55% -7.15%
SHAREHOLDERS EQUITY
Retained Earnings $302.1M $256.3M
YoY Change 73.92% 67.85%
Common Stock $336.9M $327.7M
YoY Change 11.04% 10.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.100M $0.00
YoY Change 9000.0%
Treasury Stock Shares
Shareholders Equity $412.1M $389.9M
YoY Change
Total Liabilities & Shareholders Equity $2.118B $2.079B
YoY Change 0.91% 2.61%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $51.50M $25.20M
YoY Change 93.61% 231.58%
Depreciation, Depletion And Amortization $11.70M $11.30M
YoY Change 4.46% 8.65%
Cash From Operating Activities $22.40M $45.60M
YoY Change 148.89% 623.81%
INVESTING ACTIVITIES
Capital Expenditures $7.500M $16.50M
YoY Change 127.27% 81.32%
Acquisitions
YoY Change
Other Investing Activities $500.0K $1.800M
YoY Change -129.41% 100.0%
Cash From Investing Activities -$7.000M -$14.70M
YoY Change 40.0% 79.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.100M
YoY Change 9000.0%
Debt Paid & Issued, Net $50.10M
YoY Change 28.79%
Cash From Financing Activities -$30.50M -31.40M
YoY Change 1120.0% 248.89%
NET CHANGE
Cash From Operating Activities $22.40M 45.60M
Cash From Investing Activities -$7.000M -14.70M
Cash From Financing Activities -$30.50M -31.40M
Net Change In Cash -$16.60M -500.0K
YoY Change -396.43% -95.41%
FREE CASH FLOW
Cash From Operating Activities $22.40M $45.60M
Capital Expenditures $7.500M $16.50M
Free Cash Flow $14.90M $29.10M
YoY Change 161.4% -1139.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 hy Accrued Dividend To Redeemable Noncontrolling Interests
AccruedDividendToRedeemableNoncontrollingInterests
200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
51500000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26600000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
820800000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
235700000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
174400000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
151900000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
131800000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
83800000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
42600000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
8900000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
10200000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000.0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1800000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000.0 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1700000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6900000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6700000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76900000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35900000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25100000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8700000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
51800000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
27200000 usd
CY2024Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
200000 usd
CY2023Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
200000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-100000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
200000 usd
CY2024Q1 hy Accrued Dividend To Redeemable Noncontrolling Interests
AccruedDividendToRedeemableNoncontrollingInterests
200000 usd
CY2023Q1 hy Accrued Dividend To Redeemable Noncontrolling Interests
AccruedDividendToRedeemableNoncontrollingInterests
200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
51500000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26600000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.97
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.93
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.55
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.3250
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.3225
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17339000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17049000.000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17592000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17214000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
51800000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11600000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-15100000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
1400000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-7300000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-10900000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
800000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
600000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
28100000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
51700000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
200000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
200000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-100000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
200000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
200000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27800000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50900000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
51800000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
27200000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11700000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11200000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
300000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-500000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-300000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9200000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4900000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4400000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5700000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4100000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2800000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28200000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12700000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
37600000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48100000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7700000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7400000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
45300000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16200000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-30500000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9200000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22400000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9000000.0 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7500000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3300000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
500000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400000 usd
CY2024Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
0 usd
CY2023Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
1100000 usd
CY2024Q1 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
0 usd
CY2023Q1 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
3200000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7000000.0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5000000.0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
47200000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
40300000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
50100000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
38900000 usd
CY2024Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
12800000 usd
CY2023Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
-1800000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5700000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5600000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9100000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30500000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2500000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1500000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4100000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16600000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5600000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78800000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59000000.0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64600000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-4000000.0 usd
CY2023Q1 hy Noncontrolling Interest Decrease From Sale
NoncontrollingInterestDecreaseFromSale
700000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position of the Company as of March 31, 2024 and the results of its operations and changes in equity for the three months ended March 31, 2024 and 2023, and the results of its cash flows for the three months ended March 31, 2024 and 2023 have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated balance sheet at December 31, 2023 has been derived from the audited financial statements at that date but does not include all of the information or notes required by GAAP for complete financial statements.</span></div>
CY2024Q1 us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
-200000 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
80700000 usd
CY2024Q1 us-gaap Revenues
Revenues
1056500000 usd
CY2023Q1 us-gaap Revenues
Revenues
999300000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
83800000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
42600000 usd
CY2024Q1 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
Revenue is recognized when obligations under the terms of a contract with the customer are satisfied, which occurs when control of the trucks, parts or services are transferred to the customer. Revenue is measured as the amount of consideration expected to be received in exchange for transferring goods or providing services. The satisfaction of performance obligations under the terms of a revenue contract generally gives rise for the right to payment from the customer. The Company's standard payment terms vary by the type and location of the customer and the products or services offered. Generally, the time between when revenue is recognized and when payment is due is not significant. Given the insignificant days between revenue recognition and receipt of payment, financing components do not exist between the Company and its customers. Taxes collected from customers are excluded from revenue. The estimated costs of product warranties are recognized as expense when the products are sold. See Note 10 for further information on product warranties.
CY2024Q1 us-gaap Revenue Performance Obligation Satisfied At Point In Time Transfer Of Control
RevenuePerformanceObligationSatisfiedAtPointInTimeTransferOfControl
The majority of the Company's sales contracts contain performance obligations satisfied at a point in time when title and risks and rewards of ownership have transferred to the customer. Revenues for service contracts are recognized as the services are provided
CY2024Q1 us-gaap Revenue Information Used To Assess Variable Consideration Constraint
RevenueInformationUsedToAssessVariableConsiderationConstraint
The Company also records variable consideration in the form of estimated reductions to revenues for customer programs and incentive offerings, including special pricing agreements, promotions and other volume-based incentives. Lift truck sales revenue is recorded net of estimated discounts. The estimated discount amount is based upon historical experience and trend analysis for each lift truck model. In addition to standard discounts, dealers can also request additional discounts that allow them to offer price concessions to customers. From time to time, the Company offers special incentives to increase market share or dealer stock and offers certain customers volume rebates if a specified cumulative level of purchases is obtained.
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q1 us-gaap Revenues
Revenues
1056500000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2023Q1 us-gaap Revenues
Revenues
999300000 usd
CY2024Q1 us-gaap Revenue Performance Obligation Description Of Returns And Other Similar Obligations
RevenuePerformanceObligationDescriptionOfReturnsAndOtherSimilarObligations
When customers are given the right to return eligible parts and accessories, the Company estimates the expected returns based on an analysis of historical experience. The Company adjusts estimated revenues at the earlier of when the most likely amount of consideration expected to be received changes or when the consideration becomes fixed.
CY2024Q1 us-gaap Revenue Performance Obligation Satisfied Over Time Method Used Description
RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
The Company recognizes revenue for extended warranty and maintenance agreements based on the standalone selling price over the life of the contract, which reflects the costs to perform under these contracts and corresponds with, and thereby depicts, the transfer of control to the customer.
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
92500000 usd
CY2024Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
13500000 usd
CY2024Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
25100000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76900000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35900000 usd
CY2024Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
16100000 usd
CY2023Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
7500000 usd
CY2024Q1 hy Effective Income Tax Rate Reconciliation Interim Adjustment Amount
EffectiveIncomeTaxRateReconciliationInterimAdjustmentAmount
200000 usd
CY2023Q1 hy Effective Income Tax Rate Reconciliation Interim Adjustment Amount
EffectiveIncomeTaxRateReconciliationInterimAdjustmentAmount
-300000 usd
CY2024Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5300000 usd
CY2023Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-400000 usd
CY2024Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3400000 usd
CY2023Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1700000 usd
CY2024Q1 hy Effective Income Tax Rate Reconciliation Discrete Adjustments Amount
EffectiveIncomeTaxRateReconciliationDiscreteAdjustmentsAmount
-100000 usd
CY2023Q1 hy Effective Income Tax Rate Reconciliation Discrete Adjustments Amount
EffectiveIncomeTaxRateReconciliationDiscreteAdjustmentsAmount
-200000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25100000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8700000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
448100000 usd
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
447300000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
466700000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
464000000 usd
CY2024Q1 us-gaap Discussion Of Objectives For Using Interest Rate Derivative Instruments
DiscussionOfObjectivesForUsingInterestRateDerivativeInstruments
The Company uses interest rate swap agreements to partially reduce risks related to floating rate financing agreements that are subject to changes in the market rate of interest. Terms of the interest rate swap agreements require the Company to receive a variable interest rate and pay a fixed interest rate. The Company's interest rate swap agreements and the associated variable rate financings are predominately based upon the one-month Secured Overnight Financing Rate ("SOFR"). Changes in the fair value of interest rate swap agreements that are effective as hedges are recorded in OCI. Deferred gains or losses are reclassified from OCI to the unaudited condensed consolidated statements of operations in the same period as the gains or losses from the underlying transactions are recorded and are generally recognized in interest expense.
CY2024Q1 us-gaap Interest Rate Derivatives At Fair Value Net
InterestRateDerivativesAtFairValueNet
13600000 usd
CY2023Q4 us-gaap Interest Rate Derivatives At Fair Value Net
InterestRateDerivativesAtFairValueNet
11900000 usd
CY2024Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
6500000 usd
CY2024Q1 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
19800000 usd
CY2023Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
23000000.0 usd
CY2024Q1 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
29500000 usd
CY2023Q4 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
24500000 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
400000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
3400000 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
1100000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
2200000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
20200000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
26400000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
30600000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
26700000 usd
CY2024Q1 hy Derivative Asset Fair Value Gross Asset By Counterparty
DerivativeAssetFairValueGrossAssetByCounterparty
14700000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
1100000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
13600000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
13600000 usd
CY2024Q1 hy Derivative Liability Fair Value Gross Liability By Counterparty
DerivativeLiabilityFairValueGrossLiabilityByCounterparty
25100000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
1100000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
24000000.0 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
24000000.0 usd
CY2023Q4 hy Derivative Asset Fair Value Gross Asset By Counterparty
DerivativeAssetFairValueGrossAssetByCounterparty
14400000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
2500000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
11900000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
11900000 usd
CY2023Q4 hy Derivative Liability Fair Value Gross Liability By Counterparty
DerivativeLiabilityFairValueGrossLiabilityByCounterparty
14700000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
2500000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
12200000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
12200000 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-3300000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-100000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
453500000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
395900000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
35200000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39200000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
448100000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
471500000 usd
CY2024Q1 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
936800000 usd
CY2023Q4 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
906600000 usd
CY2024Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
94900000 usd
CY2023Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
90900000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
841900000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
815700000 usd
CY2024Q1 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.52
CY2023Q4 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.49
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
68100000 usd
CY2024Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
14500000 usd
CY2024Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
100000 usd
CY2024Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8800000 usd
CY2024Q1 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-500000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
73200000 usd
CY2024Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
161600000 usd
CY2023Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
162400000 usd
CY2024Q1 hy Guarantor Obligations Collateral
GuarantorObligationsCollateral
218400000 usd
CY2024Q1 hy Percentage Of Loan Losses Guaranteed
PercentageOfLoanLossesGuaranteed
0.075
CY2024Q1 hy Loan Losses Guaranteed
LoanLossesGuaranteed
14000000 usd
CY2024Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
161600000 usd
CY2024Q1 hy Guarantor Obligations Related Party Disclosures
GuarantorObligationsRelatedPartyDisclosures
152500000 usd
CY2024Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
161600000 usd
CY2024Q1 hy Guarantor Obligations Related Party Disclosures
GuarantorObligationsRelatedPartyDisclosures
152500000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
8900000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
51500000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26600000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.93
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
51500000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26600000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001173514-24-000072-index-headers.html Edgar Link pending
0001173514-24-000072-index.html Edgar Link pending
0001173514-24-000072.txt Edgar Link pending
0001173514-24-000072-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hy-20240331.htm Edgar Link pending
hy-20240331.xsd Edgar Link pending
hyex101q12024.htm Edgar Link pending
hyex102q12024.htm Edgar Link pending
hyex311q12024.htm Edgar Link pending
hyex312q12024.htm Edgar Link pending
hyex32q12024.htm Edgar Link pending
image_0.jpg Edgar Link pending
image_1.jpg Edgar Link pending
image_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hy-20240331_def.xml Edgar Link unprocessable
hy-20240331_cal.xml Edgar Link unprocessable
hy-20240331_lab.xml Edgar Link unprocessable
hy-20240331_pre.xml Edgar Link unprocessable
hy-20240331_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending